NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that it will hold a virtual three part investor series during the week of June 22, 2020. Giovanni Caforio, M.D., chairman and chief executive officer, and members of the leadership team will discuss the Company’s strategy, pipeline and business opportunities.
Investors and the general public are invited to listen to the live audio webcast of the series at https://www.bms.com/investors or by dialing (866) 428-9517 (U.S. toll free) or (224) 357-2194 (International).
The three-part series will be held at 11:30 a.m. ET on each of the following dates:
Monday, June 22nd: Early Pipeline and Immuno-Oncology
Dial in confirmation code: 6872436
Thursday, June 25th: Hematology
Dial in confirmation code: 6996004
Friday, June 26th: Immunology and Cardiovascular
Dial in confirmation code: 7948849
Presentation materials will be available at the start of each live webcast. A replay and archived edition of the presentations will be available following each event. This series replaces the originally planned Investor Day that was postponed due to the COVID-19 pandemic.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
